The global Molecular Imaging Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.

Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.

Infinity Market Research newest research report, the Molecular Imaging Agents Industry Forecast looks at past sales and reviews total world Molecular Imaging Agents sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Imaging Agents sales for 2025 through 2031. With Molecular Imaging Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Imaging Agents industry.

This Insight Report provides a comprehensive analysis of the global Molecular Imaging Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Imaging Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Molecular Imaging Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Imaging Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Imaging Agents.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Imaging Agents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Small Molecules
    Peptides
    Engineered Protein Fragments
    Aptamers
    Nanoparticles
    Others

Segmentation by Application:

    Oncology
    Cardiology
    Gastrointestinal Disorders
    Neurology Disorders
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    General Electric
    Bracco Diagnostic
    Eisai
    Guerbet

Key Questions Addressed in this Report

What is the 10-year outlook for the global Molecular Imaging Agents market?
What factors are driving Molecular Imaging Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Imaging Agents market opportunities vary by end market size?
How does Molecular Imaging Agents break out by Type, by Application?